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AbstrACt
Objectives To assess associations between periductal 
fibrosis (PDF) and bile duct dilatation (BDD) in 
ultrasonography (US) screening of population at risk of 
cholangiocarcinoma (CCA) due to residence in an endemic 
area for Opisthorchis viverrini. CCA survival rates are low, 
and early identification of risk factors is essential. BDD 
is one symptom that can identify patients at risk of CCA. 
Detection of PDF by US can also identify at-risk patients, 
at an earlier stage of CCA development. Identification of 
association between PDF and BDD will inform screening 
practices for CCA risk, by increasing the viability of PDF 
screening for CCA risk.
setting Nine tertiary care hospitals in Northeast Thailand.
Design Cross-sectional study.
Participants Study subjects in the Cholangiocarcinoma 
Screening and Care Program (CASCAP) in Northeast 
Thailand. CASCAP inclusion criteria are all residents of 
Northeast Thailand aged ≥40 years. Participants are 
recruited through CCA screening centres and through 
primary healthcare units. So far, 394 026 have been 
enrolled.
Methods PDF and BDD were identified through US. 
PDF was categorised into three groups, PDF1, 2 and 3, 
depending on their high echo locality in the peripheral, 
segmental and main bile duct, respectively. Associations 
between PDF and BDD were determined by adjusted OR 
and 95% CI using multiple logistic regression.
results BDD was found in 6.6% of PDF3, 1.7% of PDF2 
and 1.4% of PDF1 cases. Among PDF cases, especially 
in PDF3, BDD was found in men more than in women 
(8.9% and 4.6%, respectively). Compared with non-PDF, 
the association between PDF3 and BDD was highly 
significant (adjusted OR=5.74, 95% CI 4.57 to 7.21, 
p<0.001).
Conclusions Our findings reveal that there is a 
relationship between PDF and BDD, which is associated 
with CCA. Therefore, PDF can also be an indicator for 
suspected CCA diagnosis through US.
IntrODuCtIOn 
Cholangiocarcinoma (CCA) and hepatocel-
lular carcinoma (HCC) are ranked the most 
prevalent cancers in Southeast Asia.1–3 The 
early stages of CCA can manifest through 
obstructive jaundice, which is found in 30% 
of patients who are diagnosed with primary 
sclerosing cholangitis.4 Other liver disor-
ders—fatty liver disease, cirrhosis and liver 
mass—are likewise recognised risk factors for 
both CCA and HCC.5–10 Suspected CCA cases 
can also be identified through the presence of 
bile duct dilatation (BDD), which can be iden-
tified in suspected CCA cases through ultra-
sonography (US) screening.11 12 A previous 
study demonstrated that US screening is 
highly sensitive in identifying CCA through 
confirmed incidences of BDD.13 However, on 
strengths and limitations of this study
 ► The large size of the study population and its geo-
graphical distribution across Northeast Thailand are 
a significant strength.
 ► This is the first and largest screening programme for 
cholangiocarcinoma (CCA) in an area with the high-
est incidence in the world.
 ► CCA risk factors (periductal fibrosis and bile duct 
dilatation) were measured using ultrasonography by 
skilled radiologists.
 ► Demographic, and some health, data were self-re-
ported leading to potential bias in measurement 
of liver fluke infection, praziquantel treatment and 
pre-existing medical conditions including hepatitis 
B, hepatitis C and diabetes mellitus.
 ► Self-report could lead to prevalence underestimates 
due to the fact that subjects may not have been will-
ing to disclose sensitive or personal information.
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the detection and diagnosis of bile duct and liver disor-
ders, it is often too late to save patients with CCA and 
HCC due to the rapid progression to advanced stages of 
hepatic carcinoma.14 As well, detection of BDD by US 
requires the services of specialist radiologists, who are 
generally available only in major hospitals, limiting access 
to screening. Thus, the best way to save a patient’s life and 
prevent the likelihood of cancer development is through 
early, easily accessible, screenings to detect the risk factors 
that may lead to cancer among high-risk populations.
As well as BDD, there are several other indicators for 
CCA risk including well-accepted premalignant lesions 
such as biliary intraepithelial neoplasm and intraductal 
papillary neoplasm of the bile duct.15 16 Periductal fibrosis 
(PDF) is another abnormality of the bile duct which has 
been used to identify people at risk of developing CCA. 
This hepatobiliary abnormality is particularly prominent 
among people infected with the liver fluke, Opisthorchis 
viverrini.17–21 This infection is caused by the consumption 
of raw or lightly fermented fish products and is one of the 
key risk factors for development of CCA in the region. 
PDF is caused by the thickening of the bile duct wall, 
along the periportal space.22
The relationship between PDF and CCA is indicated 
by the regular detection of PDF in confirmed CCA cases, 
and this has been particularly common in Northeast Thai-
land where O. viverrini is endemic and a leading potential 
cause of CCA.8 As a result of this relationship, US detec-
tion has been utilised to identify people with PDF as a 
risk group for CCA development.8 20 23 24 Hepatobiliary 
abnormalities identified through ultrasound have been 
shown in other studies to correlate well with histopatho-
logical confirmation making US a valuable tool in early 
identification of these health issues.8 Importantly, PDF 
can be identified through US, but does not require the 
services of a specialist radiologist increasing the potential 
access to screening, and PDF can be detected earlier than 
BDD allowing more effective intervention.
The potential to detect the risk of CCA earlier and 
without the need for specialist radiologists, through the 
identification of PDF, may be an important breakthrough 
in reducing CCA incidence. So, both PDF and BDD have 
been recognised as indicators of CCA,8 17 but their rela-
tionship to one another has yet to be established or even 
studied in depth. Determining their relationship, such as 
learning if one precedes the other, may make a significant 
change in how we screen for CCA via US. Therefore, this 
study seeks to determine if there is an association between 
PDF and BDD among people at a high-risk CCA popula-
tion in Northeast Thailand. The results of this work will 
clarify necessary directions towards early screening meth-
odologies and appropriate cancer treatment.
MethODs
study design
This study presents data collected from the Cholangio-
carcinoma Screening and Care Program (CASCAP) in 
Northeast Thailand. CASCAP is a prospective cohort study 
that is considered the first project for CCA screening in a 
high-risk population with a community-based bottom-up 
approach.25 Although this overall project is a prospective 
cohort study, the results presented here use cross-sectional 
data from the baseline study carried out with participants.
The overall aim of the study is to recruit all adults aged 
≥40 years who reside in Northeast Thailand and to screen 
them for CCA and its risk factors in terms of hepatobi-
liary abnormalities and infection with the liver fluke O. 
viverrini. As such, there are no strict inclusion or exclu-
sion criteria apart from age group and place of residence. 
Once consent has been obtained, the participants will be 
enrolled in the programme. The primary place of recruit-
ment for this cohort study were nine tertiary care hospitals 
in the Northeast of Thailand. These hospitals serve as the 
main source of affordable tertiary care for local people 
in the region. Subjects were recruited at these hospitals 
in two ways. First, the screening group comprised indi-
viduals who had attended the hospital for other reasons 
and were invited to receive ultrasound screening without 
evidencing any symptoms. The second group, the walk-in 
group, were individuals who were attending the hospital 
because of CCA symptoms and this group can then 
receive treatment. All participants were asked to join the 
project by signing a consent form. All CCA patients were 
diagnosed and treated according to routine, real-world 
clinical practice by participating hospitals. Patients were 
followed-up and provided with either clinical or palliative 
care depending on the stage of their disease. Treatment 
outcomes were recorded. Follow-up took place every 3–6 
months depending on the patient’s condition and unless 
scheduled otherwise.
study population
Our study recruited subjects from among people who 
participated in the CASCAP project. These subjects form 
two groups (screening and walk-in). The screening group 
comprised people who have undergone routine US and 
who showed no symptoms that could be related to CCA. 
The walk-in group comprised people who come to the 
hospital with symptoms indicating CCA, which has been 
diagnosed with US. The subjects included in our study 
were only those enrolled in the CASCAP database from 
2013 to 2017 with a total of 394 026 subjects.
Patient and public involvement
The CASCAP project is a comprehensive screening and 
treatment programme for CCA. Members of the public 
were first involved in the research in two ways. First when 
members of the public attended a participating hospital 
for any reason, hospital staff would actively recruit them to 
the study. Village health volunteers also recruited partici-
pants while carrying out their work. A second group were 
those who already has some suspected symptoms and 
attended a hospital for screening at which point they were 
recruited into the study. The study participants were not 
directly involved in the design of the study. Participants 
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will be contacted at least annually to be screened for CCA 
risk. Patients identified as having CCA will receive stan-
dard care for the condition through the project. For the 
screening procedures covered by this report, participants 
are informed of the purpose, outcomes and implications 
of these procedures.
Main outcome and independent variables
The primary outcome of this study was BDD which was 
categorised into two groups (no/yes). The independent 
variable of interest was PDF. We classify PDF into three 
categories (PDF1, 2 and 3) using a WHO standard meth-
odology originally developed for use in the assessment of 
schistosomal periportal fibrosis (PPF) but which is also 
valid for the study of PDF given that PPF and PDF have the 
same ultrasound images of Increased Periportal Echo.26 
We used only three of the five classifications utilised in 
this methodology since anatomically extrahepatic and 
intrahepatic bile ducts run in parallel to the portal vein 
in the periportal space, so the pathology of the bile duct 
should be detected first in the periportal space. This 
identification system has been validated by comparing US 
diagnoses with histopathologically proven cases of PDF 
with good agreement between the methods.8 Using this 
system, PDF is categorised based on the anatomical loca-
tion of the intrahepatic and extrahepatic bile duct. PDF1 
is defined as having a high echo in the wall of small bile 
ducts scattered in the liver in a starry sky pattern, PDF2 is 
a high echo along the segmental bile duct wall running 
parallel with the portal vein and PDF3 is a high echo 
along the main bile duct wall running parallel with the 
portal vein in the periportal space.19
Both BDD and PDF were diagnosed via US by radiol-
ogists from the CASCAP project, all of whom took part 
in a special training course for ultrasound examination 
including all criteria to diagnose hepatobiliary abnormal-
ities. A teleconsultation system was also set up to confirm 
diagnoses from radiologists. Demographic character-
istics of PDF and non-PDF subjects were the indepen-
dent variables including gender, age, education levels, 
occupations, having a relative diagnosed with CCA, liver 
fluke infection, praziquantel (PZQ) treatments, smoking 
(current or previous), alcohol consumption (current or 
previous) and diagnosis with hepatitis B (HB), hepatitis 
C (HC) and diabetes mellitus (DM). All demographic 
characteristics listed above were collected via face-to-
face interview by interviewer from the CASCAP using 
questionnaire.
statistical analysis
The demographic characteristics that were categorical 
data were summarised using frequencies and percentages 
(ie, gender, age groups, education levels, occupations, 
having a relative diagnosed with CCA, liver fluke infec-
tion, PZQ treatments, smoking history, alcohol consump-
tion history and diagnosis with HB, HC, DM and PDFs). 
The continuous data, such as the age of the subjects, were 
summarised by their mean, SD, median, minimum and 
maximum range.
The prevalence of BDD was calculated and the 
percentage of the prevalence was computed based on 
a normal approximation to a binomial distribution. 
Bivariate analysis using simple logistic regression was 
performed to investigate the association between the 
independent factors listed above and BDD. They were 
determined by crude OR and their 95% CI. Then, multi-
variable analysis using multiple logistic regression was 
carried out to investigate the association between PDF 
and BDD as determined by the adjusted OR and 95% CI. 
The final multivariate model was adjusted for all factors 
which previous studies have reported to be associated with 
the hepatobiliary disease: PDF, gender, age, education 
levels, occupations, having a relative diagnosed with CCA, 
liver fluke infection, PZQ treatments, smoking, alcohol 
consumption as well as diagnosis with HB, HC and DM.
There were missing values for some variables due 
to unwillingness of some participants to answer some 
sociodemographic or health history questions or from 
errors in data collection. Missing values for most vari-
ables were rare with proportions missing <3% of partic-
ipants. The only variable with a significant proportion of 
missing values was that of previous liver fluke diagnosis 
(n=211 869), but this number includes those who had 
reported never having been tested for infection.
All test statistics were two-tailed, and a p-value <0.05 
was considered statistically significant. All analyses were 
performed by using a statistical package, Stata V.15.
results
Descriptive summary
The demographic characteristics of subjects were 
presented as numbers and percentages. A total of 394 
026 subjects who underwent US screenings for CCA were 
enrolled in our study. The subjects were all between the 
ages of 40 and 100 years old and reported a mean age of 
54.92±9.03 years. Of these, approximately two-thirds were 
women (61.4%), and the majority of them completed 
primary school education level (72.9%) and worked as 
farmers (77.9%). About one-third (29.7%) had ever used 
PZQ treatment, and about one-fourth (21.3%) reported 
being a smoker or ex-smoker. As per the data of PDF 
diagnosis, 17.6% have positive diagnosis and the highest 
percentage was in subjects diagnosed with PDF1 (12.3%) 
while only 0.6% had PDF3 (table 1).
Prevalence of bDD
From this study, the overall prevalence of BDD was 
reported to be 1.2%. The highest prevalence of BDD was 
6.6% from the PDF3 group under PDF. PDF1 and PDF2 
subjects reported a low prevalence rate of only 1.4% and 
1.7%, respectively (table 2). Our study found that the 
prevalence of BDD occurring in PDF subjects was high 
in men than in women, particularly in PDF3 (8.9% and 
4.6%, respectively) (figure 1). Meanwhile, we also found 
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the number of BDD in PDF1 subjects was highest among 
people aged 55 years old (figure 2).
Associations with bDD
Bivariate analysis
The crude analysis using simple logistic regression found 
the variable with the strongest association to BDD to be 
PDF3 compared with non-PDF (OR=6.35, 95% CI 5.40 to 
7.46, p<0.001). Other factors that were significantly asso-
ciated with BDD included gender, with men being more 
affected by BDD than women; age, with a progressively 
increasing OR; lower education levels; occupation that 
was unemployed; infected liver fluke; PZQ used, with a 
progressively increasing OR; having a history of smoking 
and alcohol consumption; being positive for DM diag-
nosis (table 2).
Multivariable analysis
Through the multivariable analysis using multiple logistic 
regression, all factors were adjusted and the association 
of PDF3 subjects having BDD remained significantly high 
compared with non-PDF subjects (adjusted OR=5.74, 
Table 1 Baseline demographic and clinical characteristics 
of subjects
Characteristics No (n=394 026) %
Gender
  Female 242 115 61.4
  Male 151 866 38.6
  Missing data (n=45)
Age group (years)
  40–44 49 281 12.9
  45–49 71 564 18.7
  50–54 78 428 20.5
  55–59 69 530 18.2
  ≥60 years 114 305 29.8
  Mean±SD 54.92±9.03
  Median 
(minimum:maximum)
54 (40:100)
  Missing data (n=10 918)
Education levels
  None 6561 1.7
  Primary 286 840 72.9
  Secondary 78 090 19.9
  Certificate/bachelor 18 632 4.7
  Higher than bachelor 3055 0.8
  Missing data (n=848)
Occupation
  Unemployed 15 582 4.0
  Farmer 306 421 77.9
  Labour 32 420 8.2
  Own business 13 467 3.4
  Government official/state 
enterprises
13 997 3.6
  Others 11 335 2.9
  Missing data (n=804)
Relatives diagnosed with CCA
  No 319 902 81.4
  Yes 73 286 18.6
  Missing data (n=838)
Liver fluke infection
  No 113 178 62.1
  Yes 68 979 37.9
  Missing data (n=211 869)
Praziquantel treatment
  None 270 183 70.3
  One time 84 136 21.9
  Two times 18 126 4.7
  Three times 5264 1.4
  More than three times 6414 1.7
  Missing data (n=9903)
Continued
Characteristics No (n=394 026) %
Smoking history
  No 308 776 78.7
  Yes, current or previous 83 754 21.3
  Missing data (n=1496)
Alcohol consumption history
  No 214 495 54.6
  Yes, current or previous 178 564 45.4
  Missing data (n=967)
Hepatitis B
  No 382 058 98.2
  Yes 6803 1.8
  Missing data (n=5165)
Hepatitis C
  No 388 114 99.8
  Yes 747 0.2
  Missing data (n=5165)
Diabetes mellitus
  No 362 296 93.2
  Yes 26 565 6.8
  Missing data (n=5165)
Periductal fibrosis
  None 324 482 82.4
  PDF1 48 383 12.3
  PDF2 18 686 4.7
  PDF3 2475 0.6
CCA, cholangiocarcinoma; PDF, periductal fibrosis. 
Table 1 Continued 
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Table 2 Prevalence, and crude and adjusted odd ratios of BDD-associated factors and their 95% CI
Factors Subjects % BDD Crude OR Adjusted OR 95% CI P value
Over all 394 026 1.2 N/A N/A N/A N/A
Periductal fibrosis <0.001
  None 324 482 1.1 1 1
  PDF1 48 383 1.4 1.23 1.25 1.11 to 1.40
  PDF2 18 686 1.7 1.55 1.24 1.04 to 1.47
  PDF3 2475 6.6 6.35 5.74 4.57 to 7.21
Gender <0.001
  Female 242 115 0.9 1 1
  Male 151 866 1.7 2.00 1.46 1.31 to 1.63
Age group (years) <0.001
  40–44 49 281 0.6 1 1
  45–49 71 564 0.6 1.04 1.10 0.88 to 1.38
  50–54 78 428 0.9 1.44 1.42 1.15 to 1.75
  55–59 69 530 1.1 1.77 1.74 1.42 to 2.14
  ≥60 years 114 305 2.1 3.46 3.14 2.59 to 3.81
Education levels 0.472
  None 6561 1.6 1 1
  Primary 286 840 1.3 0.82 0.91 0.65 to 1.27
  Secondary 78 090 0.8 0.53 0.72 0.51 to 1.03
  Certificate/bachelor 18 632 1.1 0.71 0.81 0.53 to 1.24
  Higher than bachelor 3055 1.5 0.98 0.94 0.52 to 1.71
Occupations <0.001
  Unemployed 15 582 2.5 1 1
  Farmer 306 421 1.1 0.45 0.47 0.40 to 0.55
  Labour 32 420 1.0 0.39 0.53 0.41 to 0.67
  Own business 13 467 1.0 0.40 0.65 0.48 to 0.87
  Government/state enterprises 13 997 1.5 0.59 0.87 0.63 to 1.20
  Others 11 335 1.4 0.57 0.60 0.44 to 0.80
Relatives diagnosed with CCA 0.018
  No 319 902 1.2 1 1
  Yes 73 286 1.2 0.99 1.12 1.02 to 1.24
Liver fluke infection <0.001
  No 113 178 1.2 1 1
  Yes 68 979 1.5 1.24 1.25 1.12 to 1.39
Praziquantel treatment 0.067
  None 270 183 1.1 1 1
  One time 84 136 1.3 1.20 0.85 0.75 to 0.95
  Two times 18 126 1.5 1.33 0.93 0.79 to 1.10
  Three times 5264 1.7 1.56 1.10 0.85 to 1.43
  More than three times 6414 1.8 1.63 1.26 1.00 to 1.59
Smoking history <0.001
  No 308 776 1.0 1 1
  Yes, current or previous 83 754 2.0 2.11 1.31 1.17 to 1.46
Alcohol consumption history 0.002
  No 214 495 1.0 1 1
Continued
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95% CI 4.57 to 7.21, p<0.001) (table 2). Compared with 
crude OR, the adjusted OR of gender, age, occupa-
tions, liver fluke infection, smoking history and alcohol 
consumption history, and a positive diagnosis of DM 
remained statistically significant, while a positive diag-
nosis of HB and HC remained non-significant (figure 3). 
Our study also found that relatives diagnosed with CCA 
changed from non-significant in bivariate analysis to 
significant in multivariable analysis, while education 
levels and PZQ treatment changed from significant to 
non-significant.
DIsCussIOn
Liver cancer is one of the leading causes of death 
throughout the world.27 CCA accounts for >60% of these 
liver cancer cases with Northeast Thailand reporting the 
highest incidence in the world.28 29 PDF and BDD have 
been recognised as the key risk factors of CCA devel-
opment.8 17 21 Due to ambiguities in the relationship 
between PDF and BDD, our study investigated the prev-
alence of PDF and BDD in a high-risk CCA population 
to find if there was a presence of a statistically significant 
relationship between the two factors. Our study specifi-
cally found that the prevalence of BDD was significantly 
higher (6.6%) among subjects who were diagnosed with 
PDF3 and it was the most statistically significant associ-
ated factor of BDD (adjusted OR=5.74, 95% CI 4.57 to 
7.21, p<0.001). Although a study conducted in Japan 
concluded fibrosis and BDD as being indicators of CCA, 
they did not mention an association between them.17 In 
addition, studies conducted in Thailand report only PDF 
as a major risk factor for CCA development.8 21 30
We conducted a bivariate analysis via a simple logistic 
regression and found that gender, age and smoking 
history were the three most significant factors associated 
with BDD, and they remained significant in the multivari-
able analysis. The factor of relatives diagnosed with CCA 
became significant in multivariable analysis, but the magni-
tude of association was still relatively low, while education 
levels and PZQ treatment became non-significant. The 
Factors Subjects % BDD Crude OR Adjusted OR 95% CI P value
  Yes, current or previous 178 564 1.4 1.45 1.17 1.06 to 1.29
Hepatitis B virus 0.298
  No 382 058 1.2 1 1
  Yes 6803 1.4 1.13 1.16 0.88 to 1.52
Hepatitis C virus 0.124
  No 388 114 1.2 1 1
  Yes 747 2.0 1.69 1.69 0.87 to 3.31
Diabetes mellitus 0.011
  No 362 296 1.2 1 1
  Yes 26 565 1.6 1.37 1.20 1.04 to 1.37
BDD, bile duct dilatation; CCA, cholangiocarcinoma; PDF, periductal fibrosis; N/A, not applicable.
Table 2 Continued 
Figure 1 Percentage of BDD between men and women 
according to PDF1, 2 and 3. BDD, bile duct dilatation; PDF, 
periductal fibrosis.
Figure 2 Number of BDD in PDF subjects by age 
range. BDD, bile duct dilatation; PDF, periductal fibrosis. 
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other factors that were statistically significant in the bivar-
iate analysis but became less significant after adjusting for 
all factors in the multivariable analysis included occupa-
tions, alcohol consumption history, and being diagnosed 
with DM. Consistent with other studies,17–21 our results 
also found a significant association between current liver 
fluke infection and BDD. Liver fluke infection in North-
east Thailand mainly results from the consumption of raw 
or insufficiently fermented fish and is one of the main 
established risk factors for BDD and CCA development.
Our study found that those aged ≥60 years are more 
likely to have BDD than other age groups. Meanwhile, 
our study also found the association of BDD increased 
with increasing age. We conclude that age plays a role 
in BDD development. This result is similar to a study 
conducted in Israel between 2001 and 2002, which found 
that bile duct size increases with age and reported age was 
positively correlated with bile duct size.31 A study from 
Canada in 2014 found that older age was associated with 
bile duct diameters, which increases with age.32 There-
fore, it is not surprising that those who were in the oldest 
age group in our study had a strong association with BDD, 
which causes the bile duct to grow.
Subjects positive for HB and HC diagnosis demon-
strated a non-significant association with BDD (adjusted 
OR=1.16, 95% CI 0.88 to 1.52, p=0.298 and adjusted 
OR=1.69, 95% CI 0.87 to 3.31, p=0.124, respectively). 
Our findings are close to the results reported by 
Barusrux and colleagues in 2012 which found that HB 
and HC were not related to CCA.33 However, it is also 
important to mention contradictory results reported 
in South Korea which found that HBV infection was a 
significant risk factor for intrahepatic cholangiocar-
cinoma (ICC) development with OR=2.3, 95% CI 1.6 
to 3.3 p<0.050.34 HBV infection was also related to a 
3.4-fold risk of ICC in China.35 Another study conducted 
in Northeast Thailand in 2010 examined the association 
of HB and HC with CCA and reported a greater risk of 
CCA for those carrying the virus (OR=4, 95% CI 1.29 to 
16.44, p<0.05).36
And interestingly, those who had CCA-diagnosed rela-
tives had a higher association to BDD than those who did 
not have CCA-diagnosed relatives only 12% (adjusted 
OR=1.12, 95% CI 1.02 to 1.24, p=0.018). However, our 
results were consistent with Zhou et al, who identified 
genetic and familial risk factors as significantly contrib-
uting to the development of combined HCC-CCA through 
a bivariate analysis.37 It is worth mentioning that this 
significance could not be confirmed through a multivari-
able analysis. Other studies also demonstrate that having 
a family history of cancer is a significant associated factor 
for CCA development.38 39 A risk factor study of CCA in 
Northeast Thailand also reported patients who had a 
family history of cancer were more likely to develop CCA 
than those without a family history of liver cancer.40 Death 
or traumatic incidences influence the decision-making 
process. This may be the reason behind the lack of associ-
ation between family history of CCA and BDD in our statis-
tical analysis. Perhaps, family members who experience a 
death of CCA-diagnosed family member are more likely 
to take measures to prevent the occurrence of a second 
CCA incidence in the family. A CCA traumatic experience 
may have served as a warning for family members to avoid 
this rapid and fatal outcome. These results reveal the 
complicated nature of understanding the true risk factors 
of CCA and pathogenesis to hepatic carcinoma in certain 
Asian societies.
This study has some limitations. First, although large, 
the study population is not representative of the overall 
population of Northeast Thailand. The recruitment 
method, through tertiary hospitals, may mean that the 
study population has some underlying differences in 
health status from the general population. In partic-
ular, the prevalence of BDD and PDF in the study group 
is likely to vary from overall population prevalence. 
However, the study has internal validity meaning relation-
ships found between the various hepatobiliary abnormal-
ities and other predictive factors are still important and 
useful. Also, many of the risk factors including history 
of previous liver fluke infection (and PZQ treatment) as 
well as health behaviours in terms of smoking and alcohol 
Figure 3 The adjusted OR and crude OR of the 
associated factors of BDD. BDD, bile duct dilatation; 
CCA, cholangiocarcinoma; PDF, periductal fibrosis; PZQ, 
praziquantel.
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consumption were self-reported leading to some poten-
tial bias in their measurements.
PDF and BDD can be detected by ultrasound screening 
before any clinical symptom of CCA are evident. Additional 
further characterisation by other advanced imaging and 
endoscopic examinations is standard for differential diag-
nosis of CCA from other diseases. Histopathological confir-
mation is mandatory in patients with a surgical indication. 
Longitudinal data collection is necessary for further study 
of the relationship between PDF, BDD and CCA.
COnClusIOns
In conclusion, our key findings included identifying 
the factors associated with biliary tract disease in a high-
risk population for CCA: PDF3, male gender, older age, 
having CCA-diagnosed relatives, infected liver fluke 
and smoking history. Based on our results, patients 
should be considered suspected-CCA cases during US 
screenings in high-risk areas through the detection of 
PDF, old age (≥50 years), if they were infected for liver 
fluke, have CCA-diagnosed relatives, and are current 
or previous smokers. The interesting results regarding 
HB and HC diagnoses may need further evaluation and 
review due to some contradictions in the data. Greater 
consideration towards CCA and HCC prevention should 
be aimed at those in older age groups. Despite certain 
limitations, our data were based on a very large sample 
size and suggest a statistically robust association between 
PDF and BDD, specifically the PDF3 grouping. Early and 
routine screening of BDD and PDF may provide a means 
to reduce the incidence of liver-related diseases and CCA. 
Future planning of CCA surveillance should focus on 
early screening for both PDF and BDD.
recommendations
This study was conducted in Northeast Thailand and may 
not reflect the general population. Further study is neces-
sary in the region to test the generality of our results. 
Nevertheless, the methodology and results of our study 
can be used as a guideline in formulating clinical practice 
and future research priorities.
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